Calidi Biotherapeutics Inc (CLDI)
0.23
-0.01
(-2.54%)
USD |
NYAM |
May 22, 09:40
Calidi Biotherapeutics Net Income (Quarterly): -7.225M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -7.225M |
December 31, 2023 | -8.229M |
September 30, 2023 | -2.024M |
March 31, 2023 | -6.462M |
Date | Value |
---|---|
December 31, 2022 | -7.756M |
September 30, 2022 | -5.355M |
December 31, 2021 | -3.489M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-8.229M
Minimum
Dec 2023
-2.024M
Maximum
Sep 2023
-5.791M
Average
-6.462M
Median
Mar 2023
Net Income (Quarterly) Benchmarks
Minerva Neurosciences Inc | -8.569M |
Viking Therapeutics Inc | -27.36M |
CytomX Therapeutics Inc | 13.79M |
Genprex Inc | -5.969M |
Janux Therapeutics Inc | -14.76M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 6.752M |
EPS Diluted (Quarterly) | -0.20 |
Enterprise Value | 18.49M |
Earnings Yield | -326.8% |